Thyroid cancer – Diagnostics – Overview of Information and Clinical Research

Thyroid cancer diagnostics involve a series of tests that help doctors identify whether abnormal growth in the thyroid gland is cancerous, determine its type, and plan the most appropriate treatment. Early and accurate diagnosis is crucial because most thyroid cancers are highly treatable, especially when detected early.

Introduction: Who Should Undergo Thyroid Cancer Diagnostics

Not everyone needs to be tested for thyroid cancer. However, certain situations should prompt a visit to a healthcare provider for further evaluation. If you notice a lump or swelling in the front of your neck, especially in the area below or near your Adam’s apple, it is important to have it checked. Many people with early-stage thyroid cancer do not experience obvious symptoms, which is why these lumps are often discovered during routine physical examinations when a doctor feels the neck area^[1]^[18].

While most lumps in the neck turn out to be benign—meaning they are not cancer—healthcare providers take them seriously because thyroid cancer can develop in this area. In addition to a noticeable lump, other warning signs include persistent hoarseness, difficulty swallowing or breathing, swollen lymph nodes in the neck, or pain in the throat or neck region. If you experience any of these symptoms, it is advisable to seek medical attention^[2]^[7].

Certain groups of people should be especially vigilant. Women are three times more likely to develop thyroid cancer compared to men, and the disease is commonly diagnosed in women in their 40s and 50s and men in their 60s and 70s. However, thyroid cancer can affect all age groups, including children. People with a family history of thyroid cancer, those who have been exposed to high levels of radiation to the head or neck, and individuals with certain inherited genetic conditions also face higher risk and may benefit from earlier or more regular monitoring^[1]^[2].

There is no standard routine screening program for thyroid cancer in the general population. This means that unless you have symptoms or specific risk factors, you will not be routinely tested. However, if a healthcare provider suspects a problem during a physical exam, they will recommend diagnostic tests to investigate further^[18].

⚠️ Important

A lump in your neck does not automatically mean cancer. Most thyroid nodules—abnormal growths of thyroid cells—are benign. In fact, only about 3 out of 20 thyroid nodules are diagnosed as cancerous. It is important not to panic if you discover a lump, but you should have it evaluated by a healthcare provider to determine whether further testing is needed^[6]^[11].

Diagnostic Methods Used to Identify Thyroid Cancer

Once a healthcare provider suspects thyroid cancer based on symptoms or physical examination, a series of diagnostic tests are used to confirm the diagnosis, determine the type of cancer, and assess how far it may have spread. These classic diagnostic methods are designed to provide clear answers and help distinguish thyroid cancer from other, non-cancerous thyroid conditions.

Physical Examination and Medical History

The diagnostic process typically begins with a thorough physical examination. Your doctor will carefully feel your neck to detect any lumps, nodules, or areas of abnormal swelling in the thyroid region. They will also check the lymph nodes in your neck to see if they are enlarged, as thyroid cancer can spread to nearby lymph nodes. During this visit, your doctor will ask about your medical history, including any family history of thyroid cancer, past exposure to radiation, and any symptoms you have been experiencing^[10]^[21].

Blood Tests

Blood tests are often performed to check the levels of hormones produced by the thyroid gland. These tests measure thyroid-stimulating hormone (TSH) and thyroid hormones such as T3 and T4. These tests help determine whether the thyroid gland is functioning normally. For patients with suspected medullary thyroid cancer—a rarer type of thyroid cancer—blood tests may also measure levels of calcitonin, a hormone produced by certain thyroid cells. Blood tests for antithyroid antibodies may also be done to check for other types of thyroid disease^[6]^[11].

It is important to understand that blood tests do not directly diagnose thyroid cancer. Instead, they provide information about thyroid function and can help rule out other conditions. Even if thyroid function is normal, a person can still have thyroid cancer, which is why imaging and biopsy are essential^[10].

Thyroid Ultrasound

A thyroid ultrasound is one of the most important diagnostic tools for evaluating thyroid nodules. This imaging test uses sound waves to create detailed pictures of the thyroid gland and can show the size, shape, and structure of any nodules. Ultrasound can help doctors determine whether a nodule is solid or filled with fluid, and whether it has characteristics that are more likely to be cancerous. For example, certain features such as irregular borders, increased blood flow, or tiny calcium deposits within a nodule may raise concern^[10]^[21].

The ultrasound is painless and does not involve radiation. It is often the first imaging test performed after a physical exam identifies a suspicious lump. The ultrasound can also help guide the next step in diagnosis, which is often a biopsy^[14].

Fine-Needle Aspiration Biopsy

A fine-needle aspiration biopsy (FNA) is the most reliable way to determine whether a thyroid nodule is cancerous. During this procedure, a thin needle is inserted into the thyroid nodule, often with ultrasound guidance to ensure accuracy. A small sample of cells is removed and sent to a laboratory, where a specialist called a pathologist examines the cells under a microscope. The pathologist looks for signs of cancer and determines the type of cells present^[6]^[11].

The fine-needle aspiration biopsy is usually performed in a doctor’s office or clinic, and it takes only a few minutes. Most patients experience minimal discomfort, and no anesthesia is typically required. The results of the biopsy help doctors decide whether surgery or further testing is necessary. In some cases, the biopsy results are inconclusive, meaning the cells do not clearly show whether the nodule is benign or cancerous. In these situations, additional tests or monitoring may be recommended^[18].

Imaging Tests

In addition to ultrasound, other imaging tests may be used to assess the extent of thyroid cancer or to check whether it has spread to other parts of the body. Computed tomography (CT) scans use X-rays to create detailed cross-sectional images of the body. CT scans of the neck and chest can show whether cancer has spread to lymph nodes or nearby structures. Magnetic resonance imaging (MRI) uses magnetic fields and radio waves to produce detailed images and may be used in certain cases^[10].

A chest X-ray may be performed to check whether thyroid cancer has spread to the lungs, as some types of thyroid cancer can metastasize to distant organs. Positron emission tomography (PET) scans use a small amount of radioactive material to highlight areas of active cancer growth and may be used in advanced cases or when recurrence is suspected^[6].

Radioactive Iodine Scan

A radioactive iodine scan, also known as a thyroid scan, may be used to evaluate thyroid nodules and determine how much iodine the thyroid gland absorbs. Because thyroid cells naturally absorb iodine, this test can help identify areas of abnormal thyroid tissue. However, this test is more commonly used after surgery to check for any remaining thyroid tissue or cancer cells, rather than as an initial diagnostic tool^[6].

Molecular Testing

In cases where a fine-needle aspiration biopsy result is unclear or indeterminate, molecular testing may be performed on the biopsy sample. This advanced test looks for specific genetic changes or mutations in the thyroid cells that are commonly associated with thyroid cancer. Molecular testing can help doctors better predict whether a nodule is likely to be cancerous and can guide treatment decisions^[14].

⚠️ Important

The combination of physical examination, blood tests, ultrasound, and fine-needle aspiration biopsy provides a comprehensive picture of whether thyroid cancer is present. Each test plays a specific role, and your doctor will choose the tests that are most appropriate for your situation. Do not hesitate to ask your healthcare provider to explain why a particular test is being recommended and what information it will provide^[10].

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments, procedures, or diagnostic methods for thyroid cancer. For patients who are considering participating in a clinical trial, specific diagnostic tests and criteria are used to determine whether they are eligible to enroll. These tests help ensure that the trial is safe for participants and that the results are reliable and scientifically valid.

Comprehensive High-Resolution Ultrasound

After a diagnosis of thyroid cancer is confirmed, a comprehensive, high-resolution ultrasound of the neck is often required before enrolling in a clinical trial. This ultrasound provides detailed images of the thyroid gland, any tumors, and the surrounding lymph nodes. Because papillary thyroid cancer and other types of thyroid cancer commonly spread to lymph nodes in the neck, this imaging is essential for staging the disease and determining whether a patient meets the criteria for a particular trial^[10]^[21].

Blood Tests for Tumor Markers

Certain blood tests may be required to assess the presence of specific tumor markers. For patients with medullary thyroid cancer, blood levels of calcitonin and another marker called carcinoembryonic antigen (CEA) are often measured. These markers can provide information about the extent of the disease and how well it is responding to treatment. Clinical trials may use these markers as criteria for enrollment or as measures of treatment effectiveness^[6].

Imaging Studies to Assess Disease Spread

Clinical trials often require imaging studies to determine the stage of thyroid cancer and whether it has spread to other parts of the body. CT scans, MRI scans, and PET scans may be performed to evaluate the presence of metastatic disease. These scans help researchers understand the extent of the cancer and whether a patient is a good candidate for a particular experimental treatment^[10].

Molecular and Genetic Testing

Many modern clinical trials focus on targeted therapies that work by attacking specific genetic mutations or molecular changes in cancer cells. As a result, patients may need to undergo molecular or genetic testing of their tumor tissue to determine whether they have the specific mutations that the trial is targeting. For example, some trials for advanced thyroid cancer require testing for mutations in the BRAF gene or other genes involved in cancer growth. These tests are typically performed on tissue obtained from a biopsy or surgical specimen^[4]^[6].

Staging and Performance Status

Clinical trials often have strict criteria regarding the stage of cancer and the overall health and performance status of participants. Staging is based on the size of the tumor, whether it has spread to lymph nodes or other organs, and the type of thyroid cancer. Performance status refers to how well a patient is able to carry out daily activities and is often measured using standardized scales. Patients must meet specific staging and performance criteria to qualify for enrollment^[6].

Baseline Assessments and Monitoring

Before starting a clinical trial, patients undergo baseline diagnostic assessments to establish a starting point for comparison. These may include repeat imaging, blood tests, and physical examinations. Throughout the trial, regular monitoring with the same diagnostic tests is performed to track how the cancer is responding to the experimental treatment and to detect any side effects or complications^[10].

Participation in a clinical trial is a personal decision that should be made in consultation with your healthcare team. Clinical trials offer access to cutting-edge treatments that may not be available outside of research settings, but they also involve rigorous testing and monitoring. Your doctor can help you understand whether you meet the eligibility criteria for a trial and whether participation is a good option for your specific situation^[14].

Prognosis and Survival Rate

Prognosis

The prognosis for most patients with thyroid cancer is excellent. Thyroid cancer is generally highly treatable, and the disease is not life-threatening for the vast majority of patients. The outlook depends on several factors, including the type of thyroid cancer, the stage at diagnosis, the patient’s age, and whether the cancer has spread to other parts of the body. Papillary thyroid cancer, which accounts for 70 to 80 percent of all thyroid cancers, tends to grow slowly and often spreads to lymph nodes in the neck. However, even when it spreads to lymph nodes, papillary thyroid cancer has a generally excellent outlook and responds very well to treatment. Follicular thyroid cancer makes up about 10 to 15 percent of cases and can spread through the blood to distant organs such as the lungs and bones, but it is also highly treatable in most cases. More aggressive types, such as anaplastic thyroid cancer, are rarer and more difficult to treat, and they tend to grow and spread quickly^[2]^[5]^[6].

Even when thyroid cancer is more advanced, effective treatments are available for the most common forms of the disease. Factors that affect prognosis include the size of the tumor, whether the cancer has spread outside the thyroid gland, the patient’s overall health, and how well the cancer responds to treatment. Early detection and appropriate treatment can significantly improve outcomes and reduce mortality. Most patients with thyroid cancer live long, healthy lives after successful treatment^[5]^[10].

Survival Rate

Because thyroid cancer is often slow-growing, survival rates are typically measured over a 10-year period rather than the standard five-year period used for most other cancers. The average 10-year survival rate for thyroid cancer can be well over 90 percent. The overall five-year survival rate for people with thyroid cancer is 98 percent, with long-term survival being 95 percent or higher. These high survival rates reflect the fact that most thyroid cancers are detected early and respond very well to treatment. However, it is important to note that the rate of recurrence can be up to 30 percent, and recurrences can occur even decades after the initial diagnosis. Therefore, regular follow-up examinations and monitoring are essential throughout a patient’s lifetime^[5]^[7]^[18]^[22].

Despite the increase in the number of people diagnosed with thyroid cancer over recent decades, the mortality rate has remained stable. Close to 53,000 Americans receive a thyroid cancer diagnosis each year, yet approximately 2,000 people die from the disease annually. This reflects the effectiveness of current treatments and the generally favorable prognosis for most patients. Women are three times more likely to get thyroid cancer compared to men, but with early diagnosis and appropriate treatment, the prognosis remains excellent for both sexes^[2]^[7].

#1 Clinical Trials Search in Europe

Thyroid cancer – Diagnostics

Introduction: Who Should Undergo Thyroid Cancer Diagnostics